To speed up the development of your research
In 2018 PolyCrystalLine decided to launch PolyCrystalLine CDMO. A new Contract Development and Manufacturing Organization (CDMO) cGMP certified to complete the R&D Service provided by Polycrystalline SPA.
This new division will enable Polycrystalline Group to unlock integrated solutions starting from the R&D activities to the production of GMP certified Batches.
With this new site Polycrystalline intends to confirm and improve the capacity to help pharma companies, connecting our legacy of experience in solid state chemistry with their requirements for innovation, commercial manufacturing and product success.
Starting from Q3 of 2022, PolyCrystalLine CDMO will offer a comprehensive portfolio of solutions to fully control and understand your process, thus enabling consistent, robust production of cGMP quality products.
A fully integrated CDMO
Multi – Kg scale reactors
High containement systems for OEB5
Working closely with our clients allows us to tailor each project optimizing time and leading to successful results.
We are committed to continual improvement based on sound science and the use of modern technologies providing clear and trustful result.
Highly trained team of chemists and analysts with more than 15 years of experience in the discovery of new solid forms and in the development and optimization of crystallization processes.
From the discovery to the development of new APIs under the same roof with a quick and reliable technology transfer.
Our new small molecule API custom manufacturing capabilities integrated with our R&D facility will allow PolyCrystalLine CDMO to bring your project from early phase development to scale-up and commercial manufacture with our focus on the right solid forms. We have been doing this for many years. PolyCrystalLine CDMO will be a partner that you can trust.
PolyCrystalLine CDMO’s Scientists have a unique experience in design, develop and optimize robust, reliable and cost effective processes. The investment in the process development and optimization can derisk the API’s Pathway to the clinic, avoiding batch failure and tuning expensive and inefficient production operations.
A streamlined project control and management between PolyCrystalline SPA sites will guarantee besides an efficient technology transfer, an unbeatable support with the all analytical techniques available in our facilities. For more than 15 years we have been extensivly characterizing more than 500 different APIs, investing in new state of the art equiments. We won’t stop now.
Foundation of PolyCrystalLine SpA
From Start-up to Company
Purchasing of First XRay Diffractometer
Moved to custom made facility in Medicina (Bo)
First AIFA inspection
Construction of 2nd facility in Medicina (Bo)
Beginning of PolyCrystalLine CDMO project
Expansion of Laboratory in Medicina
Launch of PolyCrystalLine CDMO
Meet us at the forthcoming CPhI 2021 in Milan, from November 9 to November 11. ...
The construction work of the new facility started in Mesagne (BR), Puglia in June 2021.
Any question? Reach out to us and we’ll get back to you shortly.
Sign up for updates. Subscribe to our newsletter and receive update about PolyCrystalLine CDMO.